Do TNF Inhibitors Reduce the Risk of Myocardial Infarction in Psoriasis Patients?

• Autores: April W. Armstrong
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 309, Nº. 19, 2013, págs. 2043-2044
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Objective: To assess whether patients with psoriasis treated with tumor necrosis factor (TNF) inhibitors have a decreased risk of myocardial infarction (MI) compared with those not treated with TNF inhibitors.

    Design: Retrospective cohort study.

    Setting: Kaiser Permanente Southern California health plan.

    Patients : Patients with at least 3 International Classification of Diseases, Ninth Revision, Clinical Modification, codes for psoriasis (696.1) or psoriatic arthritis (696.0) (without antecedent MI) between January 1, 2004, and November 30, 2010.